Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study

Weisheng Chen,1 Mengjing Wang,1,2 Minmin Zhang,1 Weichen Zhang,1 Jun Shi,1 Jiamin Weng,1 Bihong Huang,1 Kamyar Kalantar-Zadeh,3– 5 Jing Chen1,2 1Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 2National Clinical Research Center for Aging and Medicine...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen W, Wang M, Zhang M, Zhang W, Shi J, Weng J, Huang B, Kalantar-Zadeh K, Chen J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	incremental hemodialysis arteriovenous vascular access residual kidney function hospitalization mortality Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/74ea8849512e427fab9553f1f8b49b20
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:74ea8849512e427fab9553f1f8b49b20
record_format	dspace
spelling	oai:doaj.org-article:74ea8849512e427fab9553f1f8b49b202021-11-14T19:00:30ZBenefits of Incremental Hemodialysis Seen in a Historical Cohort Study1178-203Xhttps://doaj.org/article/74ea8849512e427fab9553f1f8b49b202021-11-01T00:00:00Zhttps://www.dovepress.com/benefits-of-incremental-hemodialysis-seen-in-a-historical-cohort-study-peer-reviewed-fulltext-article-TCRMhttps://doaj.org/toc/1178-203XWeisheng Chen,1 Mengjing Wang,1,2 Minmin Zhang,1 Weichen Zhang,1 Jun Shi,1 Jiamin Weng,1 Bihong Huang,1 Kamyar Kalantar-Zadeh,3– 5 Jing Chen1,2 1Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 2National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 3Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA; 4Fielding School of Public Health at UCLA, Los Angeles, CA, USA; 5Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USACorrespondence: Mengjing Wang; Jing ChenDivision of Nephrology, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai, People’s Republic of ChinaTel +86 21 52889393; +86 21 52889387Fax +86 21 52889325; +86 21 52888304Email fiyona27@126.com; chenjing1998@fudan.edu.cnPurpose: Previous research on incremental hemodialysis transition has mainly focused on one or two benefits or prognoses. We aimed to conduct a comprehensive analysis by investigating whether incremental hemodialysis was simultaneously associated with adequate dialysis therapy, stable complication indicators, long-lasting arteriovenous vascular access, and long-lasting preservation of residual kidney function (RKF) without increasing mortality or hospitalization.Patients and Methods: Incident hemodialysis patients from Huashan Hospital in Shanghai, China, over the period of 2012 to 2019, were enrolled and followed every three months until death or the time of censoring. Changes in complication indicators from baseline to all post-baseline visits were analyzed by mixed-effects models. The outcomes of RKF loss, arteriovenous vascular access complications, and the composite of all-cause mortality and cardiovascular events were compared between incremental and conventional hemodialysis by Cox proportional hazards model.Results: Of the 113 patients enrolled in the study, 45 underwent incremental and 68 conventional hemodialysis. There were no significant differences in the changes from baseline to post-baseline visits in complication indicators between the two groups. Incremental hemodialysis reduced the risks of RKF loss (HR, 0.33; 95% CI, 0.14– 0.82), de novo arteriovenous access complication (HR, 0.26; 95% CI, 0.08– 0.82), and recurrent arteriovenous access complications under the Andersen–Gill (AG) model (HR, 0.27; 95% CI, 0.10– 0.74) and the Prentice, Williams and Peterson Total Time (PWP-TT) model (HR, 0.31; 95% CI, 0.12– 0.80). There were no significant differences in all-cause hospitalization or the composite outcome between groups.Conclusion: Incremental hemodialysis is an effective dialysis transition strategy that preserves RKF and arteriovenous access without affecting dialysis adequacy, patient stability, hospitalization risk and mortality risk. Randomized controlled trials are warranted.Keywords: incremental hemodialysis, arteriovenous vascular access, residual kidney function, hospitalization, mortalityChen WWang MZhang MZhang WShi JWeng JHuang BKalantar-Zadeh KChen JDove Medical Pressarticleincremental hemodialysisarteriovenous vascular accessresidual kidney functionhospitalizationmortalityTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 17, Pp 1177-1186 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	incremental hemodialysis arteriovenous vascular access residual kidney function hospitalization mortality Therapeutics. Pharmacology RM1-950
spellingShingle	incremental hemodialysis arteriovenous vascular access residual kidney function hospitalization mortality Therapeutics. Pharmacology RM1-950 Chen W Wang M Zhang M Zhang W Shi J Weng J Huang B Kalantar-Zadeh K Chen J Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
description	Weisheng Chen,1 Mengjing Wang,1,2 Minmin Zhang,1 Weichen Zhang,1 Jun Shi,1 Jiamin Weng,1 Bihong Huang,1 Kamyar Kalantar-Zadeh,3– 5 Jing Chen1,2 1Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 2National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 3Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA; 4Fielding School of Public Health at UCLA, Los Angeles, CA, USA; 5Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USACorrespondence: Mengjing Wang; Jing ChenDivision of Nephrology, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai, People’s Republic of ChinaTel +86 21 52889393; +86 21 52889387Fax +86 21 52889325; +86 21 52888304Email fiyona27@126.com; chenjing1998@fudan.edu.cnPurpose: Previous research on incremental hemodialysis transition has mainly focused on one or two benefits or prognoses. We aimed to conduct a comprehensive analysis by investigating whether incremental hemodialysis was simultaneously associated with adequate dialysis therapy, stable complication indicators, long-lasting arteriovenous vascular access, and long-lasting preservation of residual kidney function (RKF) without increasing mortality or hospitalization.Patients and Methods: Incident hemodialysis patients from Huashan Hospital in Shanghai, China, over the period of 2012 to 2019, were enrolled and followed every three months until death or the time of censoring. Changes in complication indicators from baseline to all post-baseline visits were analyzed by mixed-effects models. The outcomes of RKF loss, arteriovenous vascular access complications, and the composite of all-cause mortality and cardiovascular events were compared between incremental and conventional hemodialysis by Cox proportional hazards model.Results: Of the 113 patients enrolled in the study, 45 underwent incremental and 68 conventional hemodialysis. There were no significant differences in the changes from baseline to post-baseline visits in complication indicators between the two groups. Incremental hemodialysis reduced the risks of RKF loss (HR, 0.33; 95% CI, 0.14– 0.82), de novo arteriovenous access complication (HR, 0.26; 95% CI, 0.08– 0.82), and recurrent arteriovenous access complications under the Andersen–Gill (AG) model (HR, 0.27; 95% CI, 0.10– 0.74) and the Prentice, Williams and Peterson Total Time (PWP-TT) model (HR, 0.31; 95% CI, 0.12– 0.80). There were no significant differences in all-cause hospitalization or the composite outcome between groups.Conclusion: Incremental hemodialysis is an effective dialysis transition strategy that preserves RKF and arteriovenous access without affecting dialysis adequacy, patient stability, hospitalization risk and mortality risk. Randomized controlled trials are warranted.Keywords: incremental hemodialysis, arteriovenous vascular access, residual kidney function, hospitalization, mortality
format	article
author	Chen W Wang M Zhang M Zhang W Shi J Weng J Huang B Kalantar-Zadeh K Chen J
author_facet	Chen W Wang M Zhang M Zhang W Shi J Weng J Huang B Kalantar-Zadeh K Chen J
author_sort	Chen W
title	Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
title_short	Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
title_full	Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
title_fullStr	Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
title_full_unstemmed	Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
title_sort	benefits of incremental hemodialysis seen in a historical cohort study
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/74ea8849512e427fab9553f1f8b49b20
work_keys_str_mv	AT chenw benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT wangm benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT zhangm benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT zhangw benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT shij benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT wengj benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT huangb benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT kalantarzadehk benefitsofincrementalhemodialysisseeninahistoricalcohortstudy AT chenj benefitsofincrementalhemodialysisseeninahistoricalcohortstudy
_version_	1718428993025212416

Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study

Ejemplares similares